Document Details
Form
Filing Date
Aug 3, 2023
Document Date
Aug 1, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Inozyme Pharma, Inc.
Issuer
INOZYME PHARMA, INC.
Filer
PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.